2006
DOI: 10.1189/jlb.0406244
|View full text |Cite
|
Sign up to set email alerts
|

Neutrophils: are they hyperalgesic or anti-hyperalgesic?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
7
0
1

Year Published

2007
2007
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 14 publications
2
7
0
1
Order By: Relevance
“…Neutrophils are normally the first cell type to infiltrate damaged tissue and are essential for immunity and resistance to pathogens [24]. However, the role of neutrophils in pain has been debated [25], [26]. Our data demonstrating that neutrophils contribute to pain correlate well with published results showing that inhibition of the neutrophil chemoattractant leukotriene B 4 reduced hyperalgesia and neutrophil influx into the joint in a pre-clinical arthritis model [27].…”
Section: Discussionsupporting
confidence: 84%
“…Neutrophils are normally the first cell type to infiltrate damaged tissue and are essential for immunity and resistance to pathogens [24]. However, the role of neutrophils in pain has been debated [25], [26]. Our data demonstrating that neutrophils contribute to pain correlate well with published results showing that inhibition of the neutrophil chemoattractant leukotriene B 4 reduced hyperalgesia and neutrophil influx into the joint in a pre-clinical arthritis model [27].…”
Section: Discussionsupporting
confidence: 84%
“…Furthermore, selective and transient neutropenia delays thermal hyperalgesia following neuropathic sciatic transection (Perkins and Tracey 2000) and attenuates NGF-induced nociception (Bennett et al 1998, Bennett 1999, as well as allergen-evoked nociception (Lavich et al 2006). However, although pain is a common clinical complication of intradermal PMN accumulation (Heuft et al 2004, Marchand et al 2005, selective intradermal PMN recruitment by CXC chemokine ligands 1 and 2/3 does not induce mechanical allodynia or thermal hyperalgesia (Rittner et al 2006, also see Cunha and Verri, 2006), in agreement with personal observations following intradermal PMN injection in the rat's hindpaw. As emerging clinical data point to an association between neuropathic pain conditions and neuroinflammation (Watkins and Maier 2002), evidence that PMN might counteract inflammatory hyperalgesia by releasing opioid peptides should also be taken into consideration (Brack et al 2004, Rittner et al 2006).…”
Section: Discussionsupporting
confidence: 55%
“…For instance, it was demonstrated that during inflammation induced by CFA, the stimulation of recruited PMN with IL-1␤, corticotropin release factor, or even with stress stimulus produces an antinociceptive effect dependent on PMN production of opioids [39 -41]. These contradictions might be explained by the differences in the inflammatory models [42].…”
Section: Discussionmentioning
confidence: 99%